Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results

The Board of Directors of The Chemours Company has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer .


Ms. Dignam joined...

Related Keywords

United States ,Delaware ,American ,Mark Newman ,Matt Abbott ,Camela Wisel ,Denise Dignam ,Dupont De Nemours Inc ,Chemours Company ,Specialized Solutions ,Securities Exchange ,Eidp Inc ,Partner At Pricewaterhousecoopers ,Audit Committee ,Engineering Technology ,Information Technology ,Exchange Commission ,Audit Committee Of The Board Directors ,Linkedin ,Corteva Inc ,Interim Chief Executive Officer ,Interim Chief Financial Officer ,Titanium Technologies ,Advanced Performance Materials ,Vice President ,Global Operations ,Global Senior Business Director ,North American Business Director ,Diversified Technologies ,Industrial Resins ,Pont De Nemours ,Global Supply Chain ,Global Business Manager ,Sulfur Products ,Global Sales Manager ,Clean Technologies ,Senior Vice President ,Chief Enterprise Transformation Officer ,Enterprise Capital Projects ,Cyber Security ,Data Analytics ,Chemour Vice President ,Data Analytics Leader ,Chief Accounting Officer ,Chief Audit Executive ,Dawn Farrell ,Net Sales ,Chief Executive Officer Mark Newman ,Chief Financial Officer Jonathan Lock ,Principal Accounting Officer Camela Wisel ,Chemours Ethics Hotline ,Annual Report ,Preliminary Year End Results ,Advanced Performance Material Materials ,Glycolic Acid ,Dupont De Nemours ,Securities Act ,Securities Exchange Act ,Quarterly Report ,